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A growing number of studies have revealed that the inhibitor of apoptosis (IAP) proteins play a variety of
cellular roles in addition to suppression of apoptosis. A recent study in Molecular Cell demonstrates that
one IAP member, c-IAP1, functions to potentiate the activity of Myc by triggering the ubiquitination and
proteasomal degradation of the Myc inhibitory protein Mad1.When the inhibitor of apoptosis (iap) genes
werefirst revealed in thegenomesofhigher
eukaryotes and the term was coined, the
function implied by the name frequently
led to the mistaken assumption that all
IAPs act to suppress apoptotic cell death.
Certainly the prototype IAP,whichwasdis-
covered in the genomes of insect viruses
through an elegant screening approach
designed to identify viral gene products
capable of enhancing the survival of the
infected cell (Crook et al., 1993), lives up
to the name, but the proteins encoded by
the related cellular genes actually partici-
pate in a wide range of cellular activities.
The recent report in Molecular Cell by Xu
and coworkers (Xu et al., 2007) aptly dem-
onstrates this point.
Two important domains were originally
identified in the baculovirus IAPs. The ba-
culovirus iap repeat (BIR) is a zinc-finger-
likestructure, two tandem repeatsofwhich
arepresent in thebaculovirus IAPs. Largely
through homology searches, the genomes
ofmanyhigher eukaryotic organisms rang-
ing from yeasts to human have now been
shown to encode a group of proteins con-
taining between one and three BIRs, and
these proteins are collectively referred to
as IAPs (Vaux andSilke, 2005). The second
domain, which is characteristically foundat theextremecarboxy terminusof thepro-
type baculovirus IAP, as well as of several
cellular IAPs, is theRINGmotif. RING-con-
taining proteins have been shown to direct
the ubiquitination and proteasome-medi-
ated degradation of target proteins. Ini-
tially, the BIRs were the focus of much in-
vestigation, particularly in the mammalian
X-linked IAP (XIAP) in which the BIRs and
adjacent sequences have been shown to
directly bind to certain caspases, proteo-
lytic enzymes which are critical executors
of the apoptotic cell death program. How-
ever, a growing body of work has demon-
strated the functional significance of the
IAPRINGs, although the substrates of their
ubiquitin ligase activities have remained
largely elusive.
In their study, Xu and colleagues (Xu
et al., 2007) examine the ubiquitin ligase
properties of c-IAP1, a broadly expressed
mammalian IAP that contains three BIRs
and a RING. An interesting screening ap-
proach was taken to identify substrates
of the E3 activity of c-IAP1; specifically,
testing a collection of proteins with well-
established roles in tumorigenesis. The
study focuses on one ‘‘hit’’ from this
approach: the tumor suppressor MAD1.
The data support the notion that phys-
iologically, MAD1 levels are regulatedDevelopmentalby polyubiquitination and proteasomal
degradation through a mechanism that
involves the RING-dependent ubiquitin
ligase activity of c-IAP1.
The identification of MAD1 as a target
of c-IAP1 is intriguing for several reasons.
A pioneering study identified c-IAP1 as a
putative oncoprotein that can function co-
operatively with MYC in an experimental
murine model of hepatocellular carci-
noma (Zender et al., 2006). MAD1 is best
known as a repressor of MYC through
its ability to preferentially heterodimerize
with the MYC binding partner MAX
(Grandori et al., 2000), and so by identify-
ing MAD1 as a target of c-IAP1, the study
by Xu and colleagues provides a potential
explanation for the apparently synergistic
tumor-enhancing effects of combining
MYC and c-IAP1. Indeed, the study lends
support to such a model, using transfor-
mation assays in which endogenous
levels of c-IAP1, MAD1, and MYC were
modulated by overexpression and RNA
interference approaches, and the data
suggest not only that c-IAP1 cooperates
with MYC in tumorigenesis, but that this
cooperativity is mediated by the antago-
nism ofMAD1. Importantly, the RING-me-
diated ubiquitin ligase activity was shown
to be required for these effects.Cell 14, January 2008 ª2008 Elsevier Inc. 3
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PreviewsAnother critically important finding of
this study is that c-IAP1 was shown to
function in oncogenesis through amecha-
nism which does not appear to involve
direct apoptotic inhibition or direct inter-
action of the IAP with caspases. It is pos-
sible that while c-IAP1 might not function
as a caspase inhibitor in the classical, bio-
chemical sense, it might be able to target
caspases for polyubiquitination, which
would ultimately achieve the same effect.
Additionally, recent reports have shown
that c-IAP1 can ubiquitinate other IAPs,
and can also function as a modulator
of the signaling pathways controlling the
NF-kB transcription factor pathways by
directing the ubiquitination of key signal-
ing intermediates such as NIK (Vince
et al., 2007; Varfolomeev et al., 2007),
RIP (Petersen et al., 2007) and NEMO/
IKKg (Tang et al., 2003), and so collec-
tively these studies underscore the
biological importance of IAPs in diverse
cellular processes.
While these and other reports are
beginning to shed light on the types of
substrates that canbe recognized and tar-
geted by the RING-containing IAPs, weRetromer Retrieve
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Wntless is a sorting receptor require
retromer, permitting Wntless reutiliz
lysosomes and Wnt secretion is im
The Wnt family of secreted signaling
proteins patterns a huge variety of devel-
oping tissues throughout metazoa. In
this issue, and in an upcoming issue of
Nature Cell Biology, work from five differ-
ent labs addresses the mechanism by
which Wntless and the retromer complex
work together to promote secretion of
Wnt family proteins (Belenkaya et al.,
2008; Franch-Marro et al., 2008; Pan
et al., 2008; Port et al., 2008; Yang et al.,
2008).
4 Developmental Cell 14, January 2008 ª20still know very little about how and when
the ligase interacts with the substrate.
The key finding from over a decade ago
that c-IAP1 is recruited to the type 2 tumor
necrosis factor through its interaction with
TRAF proteins (Rothe et al., 1995) strongly
suggests a predominantly cytosolic role
as a signal transduction intermediate, yet
the study by Xu and coworkers reveals
both a nuclear and cytosolic distribution
of c-IAP1 and suggests that the nuclear
pool is likely responsible for the targeting
of MAD1. So we havemuch to learn about
how the IAPs traffic intracellularly, how
they meet their targets, and how their
ubiquitin ligase activities are triggered.
Nevertheless, the identification of the tar-
gets of these E3 ligases is an essential first
step in understanding the regulatory roles
of the IAPs normally, as well as in disease
states in which the activities of these enig-
matic proteins are deregulated.
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